Join the NVF
Donate to NVF
Contact the NVF

| Home | Scientific Community | Medical Professionals | Media Information | Search |

UV Light Phototherapy for Vitiligo
Howard University Hospital, Vitiligo Center
Rebat M. Halder, M.D., Director

PROCEDURE FOR TOPICAL PUVA THERAPY FOR VITILIGO

  • 0.1% Oxsoralen (can be in any of the following vehicles: alcohol/propylene glycol, aquaphor or acid mantle cream) is applied with a cotton-tipped swab within the margins of a vitiliginous patch.
  • The normal skin surrounding a depigmented patch is not treated.
  • Painted areas of involvement are exposed to UVA after an interval of 30 minutes.
  • An initial UVA exposure of 0.25 joules/sq cm is given (0.12 in Caucasians) with subsequent increments of 0.25 joules/sq cm with each treatment unless contraindicated (0.12 increments in Caucasians)
    a. Contraindications include excessive erythema and edema, blistering or extreme pruritus.
    b. Treatments are discontinued until the aforementioned reactions subside (usually 1 to 2 weeks).
    c. At reinstitution of therapy, UVA doses are decreased to half the previous value.
  • Once the patient maintains moderate asymptomatic erythema, no further increments are made in UVA dosage.
  • Since phototoxicity peaks in 48 to 72 hours post irradiation, treatments are scheduled only once a week.
  • Instructions are given to wash the treated sun exposed areas with soap and water, followed by the application of a broad spectrum sunscreen (SPF 15) prior ro leaving the office.

Patients are also instructed to avoid unnecessary sun exposure for the next 24 hours following treatments.

(NOTE: Topical PUVA should never be attempted with natural sunlight and should never be prescribed to the patient for home treatment. It is reserved for patients with less than 20% surface involvement with Vitiligo.)

PROCEDURE FOR ORAL PUVA THERAPY FOR VITILIGO

Baseline Laboratory
CBC, SMA, 12, SGPT, ANA
Repeat every 6 months

  • Complete baseline ophthalmological exam — initially and yearly
  • Oxsoralen Ultra (8-MOP) 0.3 mg/kg ingested 1½ hours prior to UVA light exposure
  • Initial exposure of 0.5 joules/sq cm (0.25 for skin types I & II) with subsequent increments of 0.5 joules/sq cm on every other treatment until persistent trace to 1+ erythema remains in areas of Vitiligo between treatments. If natural sunlight is used, summer mid-day initial exposure of 5 minutes increased by 5 minutes every other treatment.
  • Treatments administered twice weekly with a minimum of 48 hours between treatments.
  • Wrap-around sunglasses (i.e., NOIR) to be worn for the first 24 hours after ingestion of psoralen in the presence of any light.
  • Broad spectrum sunscreen applied to areas of Vitiligo for the first 36 hours after treatment whenever outside.

(NOTE: Oral PUVA is usually indicated for greater than 20% surface involvement with Vitiligo)







 


 


VITILIGO WORLD CONGRESS

September 23-25, 2010
Milan, Italy

Click here for details

Visit event website

 




Dhanya
Chandramohan
is our 2009 NVF
volunteer of the
year!  Click here
to read about her.


  Dhanya Chandramohan

Mission | History | Board of Directors | Contact Us | Join Community | Donate | Vitiligo Basics | Vitiligo Factsheet | Patient Handbook | Children with Vitiligo | Students with Vitiligo | Handbook for Schools | Approach to Treatment | Guidelines for Treatment | UV Light Phototherapy | Depigmentation | Cosmetic Hints | Vitamins | Find Physician | Meet and Greets | Support Groups | Insurance Help | Road Map | Current Grants | Previous Grants | Clinical Studies | Legislative Updates | Newsletters | Publications | Stories and Testimonials | Photo Gallery | Video Gallery | Resources | Vendors | Partner Groups | Privacy Policy